ألمركز الوطني لبحوث و علاج امراض الدم - رئاسة الجامعة المستنصرية
البحوث الرصينة
رابط البحث
قاعدة البيانات
تاريخ النشر
اسم المجلة
اسم الباحث
عنوان البحث
ت
scopus
26 Dec. 2022
Immunogenetics
م.د . شهلاء فاضل صابر
Assessment of regulatory T cells (Tregs) and Foxp3 methylation level in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy
1
other_w
2017
Int. Res. J. Pharm.
م.د . شهلاء فاضل صابر
Interleukin 1β level and c- reactive protein roles in primary myelofibrosis patients treated with hydroxyurea and ruxolitinibInterleukin 1β level and c- reactive protein roles in primary myelofibrosis patients treated with hydroxyurea and ruxolitinib
2
local
2018
Al-Mustansiriyah Journal of Pharmaceutical Sciences (AJPS)Al-Mustansiriyah Journal of Pharmaceutical Sciences (AJPS)
م.د . شهلاء فاضل صابر
Serum calcium and phosphate levels in patients with chronic myeloid leukemia taking different dose of tyrosine kinase inhibitors
3
scopus
2021
Medico-legal Update
م.د . شهلاء فاضل صابر
Characteristic of CD4+CD25+ T cells in chronic myeloid leukemia patients treated with imatinib mesylate with different BCR-ABL transcripts levels response
4
scopus
2021
Biochem. Cell. Arch.
م.د . شهلاء فاضل صابر
Impact of programmed death 1 expression in chronic myeloid leukemia at different molecular responses to imatinib mesylate treatment
5
other_w
2013-12
Jordan Medical Journal
م.د . شهلاء فاضل صابر
Efficacy and Tolerance of Fludarabine and Cyclophosphamide (FC) Combination Regimen in advance stage of Chronic Lymphocytic Leukemia
6
other_w
2015-09
International Journal of Innovative and Applied Research
م.د . شهلاء فاضل صابر
Discrimination of types of hypochromic microcytic anemia using screening laboratory test
7
scopus
2017-05
Int. Res. J. Pharm.
م.د . شهلاء فاضل صابر
INTERLEUKIN 1β LEVEL AND C- REACTIVE PROTEIN ROLES IN PRIMARY MYELOFIBROSIS PATIENTS TREATED WITH HYDROXYUREA AND RUXOLITINIB
8
local
2016-04
Iraqi Journal of Science
م.د . شهلاء فاضل صابر
The Correlation of Lipocalin-2 and Retinol Binding Protein-4 with the Inflammatory State in Iraqi Patients with T2DM
9
local
2017-01
Iraqi Journal of Hematology
م.د . شهلاء فاضل صابر
Assessment of interleukin-10 level and Janus kinase 2 V617F mutation incidence in patients with primary myelofibrosis
10
local
2013-11
Iraqi Journal of Hematology
م.د . شهلاء فاضل صابر
ssessment of GM-CSF Level in the Serum of Patients with Different Stages of Chronic Myeloid Leukemia Befor and After Imatinb Mesylate Therapy
11
scopus
2013-09
Cancer and Clinical Oncology
م.د . شهلاء فاضل صابر
Molecular Screening for T315I and F317L Resistance Mutations in Iraqi Chronic Myeloid Leukemia Non-Responders Patients to Imatinib
12
other_w
2013-10
Mintage Journal of Pharmaceutical & Medical Sciences
م.د . شهلاء فاضل صابر
Incidence of JAK2 V617F mutation in Iraqi patients with Philadelphia positive CML
13
scopus
2014-02
Indian Journal of Hematology and Blood Transfusion
م.د . شهلاء فاضل صابر
Assessment of Interleukin 1β Serum Level in Different Responder Groups and Stages of Chronic Myeloid Leukemia Patients on Imatinb Mesylate Therapy
